The molecular mechanisms of skeletal muscle wasting: Implications for therapy von Skipworth, R.J.E., Stewart, G.D., Ross, J.A., Guttridge, D.C., Fearon, K.C.H.

Volltext

Regulation of skeletal muscle oxidative phenotype by classical NF-κB signalling von Remels, A.H.V., Gosker, H.R., Bakker, J., Guttridge, D.C., Schols, A.M.W.J., Langen, R.C.J.

Volltext

Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice von Tang, Y, Reay, D P, Salay, M N, Mi, M Y, Clemens, P R, Guttridge, D C, Robbins, P D, Huard, J, Wang, B

Volltext

P147 MYOSIN HEAVY CHAIN IN HUMAN MUSCLE WASTING AN EARLY BIOMARKER OF CANCER CACHEXIA? von Stephens, N.A, He, W, Guttridge, K, Tan, B.H, Skipworth, R.J.E, Greig, C.A, Ross, J.A, Fearon, K.C.H, Guttridge, D.C

Volltext

Additive amelioration of ALS by co-targeting independent pathogenic mechanisms von Frakes, A.E, Braun, L, Ferraiuolo, L, Guttridge, D.C, Kaspar, B.K

Volltext bestellen

Protease nexin-1, a thrombin inhibitor, is regulated by interleukin-1 and dexamethasone in normal human fibroblasts von Guttridge, D.C., Lau, A.L., Cunningham, D.D.

Volltext